Condition: Atrial Fibrillation, Paroxysmal or Persistent · Mitral Valve Disease · Sponsor: Medinice S.A.
The study involves endocardial cryoablation of the left and/or right atrium of the heart using the CoolCryo system as an adjunct to mitral valve surgery, with the aim of eliminating atrial fibrillation (AF), which is a common sequelae of mitral valve defects and is associated with an increased risk of ischaemic stroke, heart failure and death.
This description comes directly from the study's public registry record.
Tomasz Hrapkowicz, MD PhD · +48-519-136-533 · t.hrapkowicz@sccs.pl
Always discuss trial participation with your own doctor first.
| Antoni Jurasz University Hospital No. 1 | Bydgoszcz, Poland | Recruiting |
| Silesian Centre for Heart Diseases | Zabrze, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06557616